Search

everythinglearnresearchcommunity

for

Search:↓

Men with early hair loss and certain health factors may have a higher risk of developing reproductive issues, similar to polycystic ovary syndrome in women.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Versican, a protein, is less present in thinning hair follicles and this decrease might contribute to common hair loss in men.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Certain DNA variants can predict straight hair in Europeans but are not highly specific.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Scalp flaps are stiffer than skin from other body areas, which helps in planning reconstructive and cosmetic head surgeries.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Finasteride can cause sexual problems and depression in young men.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

QR678 treatments were more effective and comfortable for male hair loss than PRP treatments.

Formulation P-08-016 better targets hair follicles for baldness treatment.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Choose hair restoration surgery candidates carefully and plan treatments for a natural look and future hair loss.

Genetic variants at 20p11 increase baldness risk in Chinese Han people.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

Androgens can both increase body hair and cause scalp hair loss.

LLLT is a safe, promising hair loss treatment, but more research needed.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Walter P. Unger suggests using advanced hair transplant techniques for broader coverage, as they provide natural results and use donor tissue efficiently, while also recommending personalized planning due to the unpredictable progression of baldness.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

MendelVar is a tool that helps identify important genes by combining GWAS data with Mendelian disease information.

Higher levels of the DP2 receptor may lead to hair loss.